News Conference News ACC 2012 Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel Jason Kahn March 24, 2012
News Conference News ACC 2012 New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding L.A. McKeown March 24, 2012
Presentation ACC 2012 Economic Impact of Transradial Percutaneous Coronary Intervention Presenter: David Safley March 24, 2012
Presentation ACC 2012 Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention Presenter: Robert A. Byrne March 24, 2012
News Conference News ACC 2012 Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation March 24, 2012
Presentation ACC 2012 Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial Presenter: Hyo-Soo Kim March 24, 2012
Video » Interview The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis May 4, 2022
Video » Interview EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries May 4, 2022
Video » Interview ACC 2022: PACMAN AMI - Effects Of Alirocumab On Coronary Atherosclerosis Assessed By Serial Multimodality Intracoronary Imaging In Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial April 12, 2022
Video » Interview ACC 2022: The FAME 3 Trial - Quality of Life After Fractional Flow Reserve-guided Stenting Compared with Coronary Bypass Surgery April 3, 2022
Video » Interview ACC 2019: The DEFINE PCI Trial: Blinded Physiologic Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention March 18, 2019